The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

A new policy shift is reshaping the landscape for GLP-1 drugs, signaling major financial effects for Medicare, insurers, and ...

The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...

The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs ...

The Trump administration negotiated lower prices on 15 costly drugs under Medicare, including Ozempic and Wegovy.

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

Shares of Novo Nordisk ($NVO) are up 3% at the time of writing after the Centers for Medicare & Medicaid Services (CMS) ...

President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for its blockbuster drug ingredient Semaglutide.